argenx SE
ARGNFOTCHealthcare● Active
$885.00
+$50.00(+5.99%)
Market Cap$54.8B
P/E Ratio—
52W High$885
52W Low$532.4
argenx SE (ARGNF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ARGNF · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2025Report Date: Jul 31, 2025EPS Actual
$4.40
Revenue
$1.12B
Est. $1.06B · +4.9%
Fiscal Period
Q3 FY2025
FY ends December
Report Date
Jul 31, 2025
After Market Close
▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
ARGNF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 23, 2026 | — | — | — | — | $1.45B | — |
| ◌ Q3 FY2026 | Jul 23, 2026 | — | — | — | — | — | — |
| ◌ Q3 FY2026 | Jul 23, 2026 | — | — | — | — | $1.24B | — |
| ◌ Q3 FY2026 | Jul 23, 2026 | — | — | — | — | — | — |
| ◌ Q1 FY2026 | Feb 26, 2026 | — | — | — | — | — | — |
| — Q3 FY2025 | Jul 31, 2025 | — | $4.40 | — | $1.12B | $1.06B | +4.9% |
| — Q1 FY2025 | Feb 27, 2025 | — | $13.77 | — | $1.39B | $0.86B | +61.8% |
| — Q4 FY2024 | Oct 31, 2024 | — | -$0.55 | — | $0.91B | $0.67B | +36.1% |
Q3 FY2026
Jul 23, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2026
Jul 23, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2026
Jul 23, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2026
Jul 23, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 26, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Jul 31, 2025
EPS Actual
$4.40
EPS Est.
—
EPS Surpr.
—
Revenue
$1.12B
Q1 FY2025
Feb 27, 2025
EPS Actual
$13.77
EPS Est.
—
EPS Surpr.
—
Revenue
$1.39B
Q4 FY2024
Oct 31, 2024
EPS Actual
-$0.55
EPS Est.
—
EPS Surpr.
—
Revenue
$0.91B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $1.2B | $1.3B | $1.4B | 20 |
| Q2 FY2026 | $1.2B | $1.2B | $1.3B | 20 |
| Q1 FY2026 | $1.0B | $1.1B | $1.2B | 19 |
| Q4 FY2025 | $1.0B | $1.1B | $1.2B | 19 |
| Q3 FY2025 | $0.8B | $0.9B | $1.0B | 21 |
| Q2 FY2025 | $0.7B | $0.8B | $0.8B | 21 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q3 FY2025 | Jul 31, 2025 | — | $547.60 | $547.60 | +0.00% |
| — Q1 FY2025 | Feb 27, 2025 | — | $697.42 | $697.42 | +0.00% |
| — Q4 FY2024 | Oct 31, 2024 | — | $525.60 | $525.60 | +0.00% |
| — Q2 FY2024 | May 9, 2024 | — | $373.50 | $442.89 | +18.58% |
| — Q2 FY2023 | Jun 30, 2023 | — | $397.90 | $384.00 | -3.49% |
| ▲ Q1 FY2023 | Mar 2, 2023 | +79.8% | No price data | $397.32 | — |
| ▼ Q4 FY2022 | Oct 27, 2022 | -17.0% | No price data | $397.32 | — |
Q3 FY2025+0.00%
Report Date
Jul 31, 2025
EPS Beat/Miss
—
Price Before
$547.60
Price After
$547.60
Q1 FY2025+0.00%
Report Date
Feb 27, 2025
EPS Beat/Miss
—
Price Before
$697.42
Price After
$697.42
Q4 FY2024+0.00%
Report Date
Oct 31, 2024
EPS Beat/Miss
—
Price Before
$525.60
Price After
$525.60
Q2 FY2024+18.58%
Report Date
May 9, 2024
EPS Beat/Miss
—
Price Before
$373.50
Price After
$442.89
Q2 FY2023-3.49%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$397.90
Price After
$384.00
Q1 FY2023—
Report Date
Mar 2, 2023
EPS Beat/Miss
+79.8%
Price Before
—
Price After
$397.32
Q4 FY2022—
Report Date
Oct 27, 2022
EPS Beat/Miss
-17.0%
Price Before
—
Price After
$397.32
Beat Rate1 / 7 quarters
Largest Move+18.58% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ARGNF ends December
argenx SE (ARGNF) most recently reported earnings on July 31, 2025 for Q3 FY2025, posting EPS of $4.40 (in line with the analyst consensus of —). The next ARGNF earnings date is expected around September 1, 2026.
Each quarter, investors track ARGNF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ARGNF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ARGNF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ARGNF earnings · 4 questionsargenx SE's next earnings report is expected around September 1, 2026. ARGNF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ARGNF historically reports after market close (AMC).
ARGNF earnings datewhen is ARGNF earningsARGNF next earnings datewhen does ARGNF report earningsARGNF earnings calendar
▸ Source: FMP · argenx SE SEC filings · US GAAP · argenx SE SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026